檢索結果 - M. Macro
- Showing 1 - 3 results of 3
-
1
P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PR... 由 H. C. Lee, Karthik Ramasamy, M. Macro, Faith E. Davies, Rafat Abonour, Frits van Rhee, Vânia Hungria, Noemí Puig, K. Ren, J. Silar, V. Enwemadu, Dasha Cherepanov, Dawn Marie Stull, Xavier Leleu
出版 2022Artigo -
2
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III) 由 Arnaud Jaccard, Raymond L. Comenzo, Parameswaran Hari, Philip N. Hawkins, Murielle Roussel, Pierre Morel, M. Macro, Jean‐Luc Pellegrin, Estibaliz Lazaro, Dania Mohty, P. Mercié, O. Decaux, JD Gillmore, David Lavergne, Frank Bridoux, Ashutosh Wechalekar, Chris Venner
出版 2014Artigo -
3
Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients 由 M.-L. Chretien, Benjamin Hébraud, V. Cances-Lauwers, C. Hulin, Gérald Marit, Xavier Leleu, Lionel Karlin, Murielle Roussel, A.-M. Stoppa, François Guilhot, Thierry Lamy, Laurent Garderet, Brigitte Pegourié, M. Dib, Catherine Sebban, Pascal Lenain, S. Brechignac, Bruno Royer, Marc Wetterwald, Laurence Legros, Frédérique Orsini‐Piocelle, Laurent Voillat, X. Delbrel, Denis Caillot, M. Macro, Thierry Façon, Michel Attal, Philippe Moreau, Hervé Avet‐Loiseau, Jill Corre
出版 2014Artigo
相關主題
Internal medicine
Medicine
Multiple myeloma
Surgery
Chemotherapy
Oncology
AL amyloidosis
Adverse effect
Amyloidosis
Antibody
Bortezomib
Carfilzomib
Cohort
Confidence interval
Cyclophosphamide
Dexamethasone
Hazard ratio
Immunoglobulin light chain
Immunology
Incidence (geometry)
Ixazomib
Lenalidomide
Melphalan
Optics
Physics
Prospective cohort study
Regimen